[1]
“Cutaneous Manifestations of IBD: Potential Role of Vedolizumab”, Can Dermatol Today, vol. 5, no. 1, pp. 22–31, Mar. 2024, Accessed: Mar. 19, 2026. [Online]. Available: https://canadiandermatologytoday.com/article/view/5-1-Lipson